Salarius Pharmaceuticals Inc

NASDAQ:SLRX   9:45:26 AM EDT
0.66
-0.02 (-3.55%)
Other Pre-Announcement

Salarius Pharmaceuticals Reports Business Highlights And Third Quarter 2020 Financial Results

Published: 11/11/2020 21:31 GMT
(SLRX) - Salarius Pharmaceuticals Reports Business Highlights and Third Quarter 2020 Financial Results.
Salarius Pharmaceuticals Inc Qtrly Loss per Share $0.10.
Salarius Pharmaceuticals Inc - Expects Its Cash and Cash Equivalents to Fund Its Operations Into Q3 of 2021.
Salarius Pharmaceuticals Inc - As of September 30, 2020, Total Cash, Cash Equivalents and Restricted Cash Were $9.6 Million.